No Data
Insider Sale: Chief Operating Officer of $AKRO Sells 4,900 Shares
Akero Therapeutics Insider Sold Shares Worth $538,061, According to a Recent SEC Filing
Why Akero Therapeutics Inc (AKRO) Is Skyrocketing So Far In 2025
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
UBS Adjusts Price Target on Akero Therapeutics to $109 From $42, Keeps Buy Rating
Akero Therapeutics(AKRO.US) Officer Sells US$5.75 Million in Common Stock
throwing us a party at CYN soon. Everyone's invited. idk bout hamburgers but we'll be doing some grillin! 
